PMI Q2 2026 Earnings: Smoke-Free Revenue Breaks $11 Billion as VEEV, IQOS, and ZYN Reshape the E-Cigarette Stock Landscape

Published: July 29, 2026 • Category: Industry Analysis • Reading time: 12 min

Philip Morris International (PMI) just posted the strongest quarter in its 177-year history. On July 22, the Stamford-based tobacco giant reported Q2 2026 net revenues of $11.2 billion, up 10.4% year-over-year, powered by an accelerating multi-category smoke-free business that now accounts for 42% of total global sales. For e-cigarette investors, supply chain executives, and industry watchers, these numbers carry a clear signal: the transition from combustible cigarettes to smoke-free alternatives has crossed a structural tipping point, and there is no turning back.

PMI’s smoke-free portfolio drives record quarterly revenue. Financial markets react to the $11 billion milestone.

The Numbers Behind the Smoke-Free Surge

PMI CEO Jacek Olczak described the quarter as “outstanding,” noting that the company “delivered net revenues to over $11 billion for the first time with excellent growth across all headline metrics.” CFO Emmanuel Babeau added that “close to plus 8% organic top line growth” was “powered by the excellent performance of our international smoke-free business.”

What makes these results remarkable is not just the headline revenue beat but the composition of growth. Smoke-free products delivered an 11.7% revenue increase (9.7% organically), while the combustible segment also contributed a 9.5% gain (6.1% organically). The combustible outperformance reflected resilient pricing power and stable category share in markets where smoke-free alternatives remain limited. But make no mistake: the engine of growth is shifting decisively.

IQOS: The Heat-Not-Burn Juggernaut Keeps Rolling

IQOS remains the backbone of PMI’s smoke-free transition. The fourth-generation IQOS ILUMA platform continues to gain traction across Europe, Asia, and the Middle East, with estimated legal-age consumers exceeding 43 million globally. PMI’s heated tobacco stick shipments grew 7.6% in the quarter, reflecting robust user acquisition in key markets like Japan, Italy, South Korea, and Indonesia.

In Japan, where IQOS dominates the heated tobacco category, Philip Morris recently launched TEREA Blossom Pearl, a capsule-based menthol variant for the ILUMA system, scheduled for May 2026 release. The company also expanded ZYN by IQOS into broader Tokyo retail distribution, signaling its multi-category strategy in action.

PMI’s Multi-Category Offensive: VEEV + ZYN + IQOS

The Q2 results validate PMI’s multi-category approach. While IQOS provides the core heated tobacco platform, two complementary categories are accelerating:

• VEEV e-vapor: Shipments surged 55.1% YoY, the fastest-growing category in PMI’s portfolio. The VEEV ONE PLUS, launched across Europe in June 2026, targets the closed-pod vaping segment that is rapidly displacing open-system and disposable devices in regulated markets.
• ZYN nicotine pouches: Now available in 60 markets. U.S. shipments reached 2.9 billion pouches. The new ZYN ULTRA product line, featuring higher-strength moisture-slim pouches, launched in Q2 and is expected to reinvigorate growth after a period of demand normalization.
• IQOS ILUMA i REMIX: A limited-edition device released globally in July 2026, combining the ILUMA i platform with seasonal design to drive accessory revenue and user engagement.

“IQOS continued to show strong underlying momentum, while other smoke-free categories, especially VEEV, also continued to grow rapidly, as our multi-category commercial approach gains momentum across markets.”
— Emmanuel Babeau, CFO, Philip Morris International (Q2 2026 Earnings Call)

BAT Follows Suit: New Category Revenue Upgraded to Mid-Teens

PMI is not alone in the smoke-free acceleration. British American Tobacco (BAT), reporting its H1 2026 pre-close trading update on June 2, upgraded its full-year new category revenue growth expectation from low double-digits to mid-teens. The upgrade was driven by two standout performers:

The contrast between BAT’s Vuse and glo is instructive. Vuse Ultra, the premium pod system launched in late 2025, generated disproportionate profit growth through premium pricing ($9.99+ per device). In tracked channels, Vuse now commands global value share leadership. Meanwhile, glo’s struggles in Japan’s heated tobacco market, driven by PMI’s IQOS dominance and BAT’s own inventory adjustments, illustrate the winner-take-most dynamics of the heat-not-burn category.

Global supply chains adapt as heated tobacco and vaping demand reshapes manufacturing priorities across Asia, Europe, and the Americas.

The SMOORE Dimension: China’s OEM Giant Downgraded Despite Growth

One often-overlooked piece of the e-cigarette stock puzzle is SMOORE International (06969.HK), the Shenzhen-based manufacturer that produces vaporizers for Vuse, NJOY, and multiple independent brands. On July 15, Daiwa Securities downgraded SMOORE from Outperform to Hold, slashing its target price from HKD17 to HKD7.6.

The downgrade was not about the business itself. Daiwa acknowledged that SMOORE’s e-cigarette product sales are “expected to deliver sales upside surprises” and that new heated tobacco customers in H2 2026 would offset BAT’s Japan inventory reduction. The issue was valuation: at 30x forward P/E for 2026, versus an OEM peer average of 14x, the market had already priced in the growth story.

“We expect SMOORE’s earnings growth to accelerate from 2027 onward, forecasting a 2026-2028 net profit CAGR of 28%. The company is well positioned to benefit from the trend of new tobacco products replacing traditional tobacco products.”
— Daiwa Securities Research, July 15, 2026

For e-cigarette supply chain investors, SMOORE’s positioning highlights a key dynamic: the OEM layer captures value as the industry grows, but margin expansion is capped by customer concentration risk. BAT’s inventory reduction in Japan, for instance, directly impacted SMOORE’s H1 HNB revenue trajectory. The key catalysts ahead are FDA enforcement against non-compliant products (which favors branded OEMs like SMOORE) and the EU’s TPD3 regulatory overhaul.

Regulatory Crosswinds: Europe’s TPD3 and the Global Policy Map

The regulatory environment is becoming both more restrictive and more complex. Three major policy developments are reshaping the landscape in H2 2026:

EU TPD3: The Biggest Regulatory Shift in a Decade

The European Union’s revision of the Tobacco Products Directive (TPD) entered its public consultation phase on June 18, with submissions open until August 14, 2026. The initial call for evidence attracted over 82,000 submissions, reflecting the intensity of industry and public health engagement. Key directions under review include:

• Expanded scope: From tobacco products to “all nicotine products,” covering nicotine pouches, gums, lozenges, and non-nicotine e-cigarettes
• Closing loopholes: The “2+10” combo systems (2ml pod + 10ml refill) and zero-nicotine products that can be mixed later
• Plain packaging: Potentially extending standardized packaging to all nicotine products
• Digital marketing controls: Stricter age verification, influencer boundaries, and product traceability

Spain Equates Vaping with Smoking

Spain’s Council of Ministers approved a draft tobacco control law on July 21 that extends smoking bans to hospitality terraces, beaches, public pools, and national parks. Crucially, e-cigarettes (including nicotine-free devices), heated tobacco, and nicotine pouches face the same restrictions as combustible cigarettes. A 15-meter protection zone around schools and hospitals is included. The bill now moves to parliament.

Southeast Asia: Vietnam, Indonesia, Malaysia Tighten

Three Asian countries simultaneously advanced restrictive policies this month. Vietnam is codifying its de facto vape ban into formal legislation. Indonesia’s President Prabowo directed agencies to develop stricter regulations citing drug abuse concerns. Malaysia’s health advocates renewed calls for a nationwide ban. For China-based manufacturers exporting to these markets, the trend is unambiguous: Southeast Asia is becoming a more difficult regulatory environment.

What This Means for E-Cigarette Stock Investors

The Q2 earnings season has clarified several investment themes in the e-cigarette sector:

Altria’s U.S. Domestic Angle

Altria Group, PMI’s former parent and exclusive U.S. distributor, reported Q1 2026 results on April 30 with $4.76 billion in net revenue and $1.32 adjusted EPS. Its FY26 guidance targets EPS of $5.56 to $5.72 (2.5% to 5.5% growth). The company remains primarily a U.S. combustible play, but its partnership dynamics with PMI on IQOS distribution and the competitive threat from BAT’s Vuse Ultra and nicotine pouch brands make it a key bellwether for the American vaping market.

Market intelligence: e-cigarette industry data flows from Q2 earnings into H2 2026 strategic planning.

Closing Outlook: The Smoke-Free Tipping Point Is Here

The Q2 2026 earnings season has made one thing clear: the global e-cigarette industry is no longer in a speculative growth phase. It is in a structural transition phase. PMI’s smoke-free business generating 42% of revenue, BAT upgrading new category guidance, and nicotine pouches expanding into 60+ markets represent inflection points that are unlikely to reverse.

Short-term catalysts to watch include: the EU TPD3 consultation closing on August 14, the UK’s Vaping Products Duty implementation in October 2026, Hawaii’s Act 190 manufacturer certification deadline on October 1, and SMOORE’s H2 2026 earnings that will reveal whether new HNB customer wins offset BAT’s Japan inventory headwind.

For the supply chain, the message is equally clear. Demand is shifting from disposable, unregulated devices toward branded, compliant, premium products. Manufacturers that invest in PMTA compliance, heated tobacco R&D, and multi-category capability will capture the next wave of growth. Those that don’t will find the regulatory door closing fast.